Introducing covid-19 as an evolutionary metabolic infectious disease (EMID). The prime cause and representing alternative treatment for Covid-19 (SARS-cov-2)
Price: $ 19.00
5(273)
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines: Trends in Molecular Medicine
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients - ScienceDirect
From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS- CoV-2) of pandemic potential infecting humans – Call for a One Health approach - ScienceDirect
COVID-19 and metabolic disease: mechanisms and clinical management - The Lancet Diabetes & Endocrinology
Frontiers Pandemics Throughout History
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies, Journal of Biomedical Science
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients: Molecular Therapy Methods & Clinical Development
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development - ScienceDirect
SAVE—NIAID's 'Avengers-Like' Research Program for Evolving Pathogens
